97 related articles for article (PubMed ID: 11244834)
21. Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese.
Horikawa Y; Oda N; Yu L; Imamura S; Fujiwara K; Makino M; Seino Y; Itoh M; Takeda J
J Clin Endocrinol Metab; 2003 Jan; 88(1):244-7. PubMed ID: 12519860
[TBL] [Abstract][Full Text] [Related]
22. Capn10, a candidate gene responsible for type 2 diabetes mellitus in the OLETF rat.
Muramatsu Y; Taniguchi Y; Kose H; Matsumoto K; Yamada T; Sasaki Y
IUBMB Life; 2003 Sep; 55(9):533-7. PubMed ID: 14658759
[TBL] [Abstract][Full Text] [Related]
23. Calpain inhibition and insulin action in cultured human muscle cells.
Logie LJ; Brown AE; Yeaman SJ; Walker M
Mol Genet Metab; 2005 May; 85(1):54-60. PubMed ID: 15862281
[TBL] [Abstract][Full Text] [Related]
24. Large-scale study of the -232C > G polymorphism of PCK1 in Type 2 diabetes.
Wegner L; Andersen G; Albrechtsen A; Sparsø T; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Diabet Med; 2006 Oct; 23(10):1140-4. PubMed ID: 16978381
[TBL] [Abstract][Full Text] [Related]
25. Genetics of type 2 diabetes mellitus: status and perspectives.
Hansen L; Pedersen O
Diabetes Obes Metab; 2005 Mar; 7(2):122-35. PubMed ID: 15715885
[TBL] [Abstract][Full Text] [Related]
26. Further evidence for a type 2 diabetes susceptibility locus on chromosome 11q.
Duggirala R; Almasy L; Blangero J; Jenkinson CP; Arya R; DeFronzo RA; Stern MP; O'Connell P;
Genet Epidemiol; 2003 Apr; 24(3):240-2. PubMed ID: 12652528
[No Abstract] [Full Text] [Related]
27. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q
J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353
[TBL] [Abstract][Full Text] [Related]
28. [Genetic susceptibility of type 2 diabetes].
Hara K; Kadowaki T
Seikagaku; 2003 Oct; 75(10):1345-60. PubMed ID: 14635526
[No Abstract] [Full Text] [Related]
29. [Type 2 diabetes and genetic variations of calpain 10 gene].
Horikawa Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():155-9. PubMed ID: 15779361
[No Abstract] [Full Text] [Related]
30. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.
Weedon MN; Schwarz PE; Horikawa Y; Iwasaki N; Illig T; Holle R; Rathmann W; Selisko T; Schulze J; Owen KR; Evans J; Del Bosque-Plata L; Hitman G; Walker M; Levy JC; Sampson M; Bell GI; McCarthy MI; Hattersley AT; Frayling TM
Am J Hum Genet; 2003 Nov; 73(5):1208-12. PubMed ID: 14574648
[No Abstract] [Full Text] [Related]
31. Calpain 10 and type 2 diabetes: are we getting closer to an explanation?
Ridderstråle M; Parikh H; Groop L
Curr Opin Clin Nutr Metab Care; 2005 Jul; 8(4):361-6. PubMed ID: 15930958
[TBL] [Abstract][Full Text] [Related]
32. Calpain-10 (NIDDM1) as a Susceptibility Gene for Common Type 2 Diabetes.
Horikawa Y
Endocr J; 2006 Oct; 53(5):567-76. PubMed ID: 16873988
[No Abstract] [Full Text] [Related]
33. Does genetic testing really improve the prediction of future type 2 diabetes?
Janssens AC; Gwinn M; Khoury MJ; Subramonia-Iyer S
PLoS Med; 2006 Feb; 3(2):e114; author reply e127. PubMed ID: 16492078
[No Abstract] [Full Text] [Related]
34. Predictive genetic testing for type 2 diabetes.
Janssens AC; Gwinn M; Valdez R; Narayan KM; Khoury MJ
BMJ; 2006 Sep; 333(7567):509-10. PubMed ID: 16960189
[No Abstract] [Full Text] [Related]
35. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.
Hanis CL; Boerwinkle E; Chakraborty R; Ellsworth DL; Concannon P; Stirling B; Morrison VA; Wapelhorst B; Spielman RS; Gogolin-Ewens KJ; Shepard JM; Williams SR; Risch N; Hinds D; Iwasaki N; Ogata M; Omori Y; Petzold C; Rietzch H; Schröder HE; Schulze J; Cox NJ; Menzel S; Boriraj VV; Chen X; Lim LR; Lindner T; Mereu LE; Wang YQ; Xiang K; Yamagata K; Yang Y; Bell GI
Nat Genet; 1996 Jun; 13(2):161-6. PubMed ID: 8640221
[TBL] [Abstract][Full Text] [Related]
36. Nurture and nature: the new science of epigenetics.
Gebel E
Diabetes Forecast; 2011 Mar; 64(3):50-1. PubMed ID: 21462871
[No Abstract] [Full Text] [Related]
37. Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene.
Cox NJ
Hum Mol Genet; 2001 Oct; 10(20):2301-5. PubMed ID: 11673414
[TBL] [Abstract][Full Text] [Related]
38. Tracking down a genetic culprit in type 2 diabetes.
Habeck M
Trends Mol Med; 2001 Feb; 7(2):46-7. PubMed ID: 11286736
[No Abstract] [Full Text] [Related]
39. Calpain-10: from genome search to function.
Turner MD; Cassell PG; Hitman GA
Diabetes Metab Res Rev; 2005; 21(6):505-14. PubMed ID: 16028216
[TBL] [Abstract][Full Text] [Related]
40. Calpain 10: the first positional cloning of a gene for type 2 diabetes?
Permutt MA; Bernal-Mizrachi E; Inoue H
J Clin Invest; 2000 Oct; 106(7):819-21. PubMed ID: 11018067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
